Clarity fuel
posted on
***** TODAY’S NEWS: Very big news for Vertex - 75% of hepatitis C patients never treated before achieved a viral cure after receiving a 12-week course of the company's experimental drug telaprevir …
Continue Reading about Impactiviti Daily 052610 Top Pharma News →
posted on
***** TODAY’S NEWS Hepatitis C, Vertex, and cocktails. Some pretty amazing stuff here about viral replication/mutation and drug resistance. Increasingly parting companies: the FDA and its advisory …
Continue Reading about Impactiviti Daily 050610 Top Pharma News →
posted on
***** TODAY’S NEWS Great news for hepatitis C treatment (and Vertex) - Adding the investigational drug telaprevir to standard treatment for hepatitis C infection cures about half the patients …
posted on
TODAY’S NEWS FDA panel to Forest on new use for heart drug: thumbs down - Federal health advisers on Monday unanimously rejected a new use of Forest Laboratories' hypertension drug for patients at …
posted on
TODAY’S NEWS Takeda buys into Amylin's weight-loss drug portfolio - Takeda will pay $75 million upfront for medicines including Amylin’s pramlintide/metreleptin and davalintide, in the second phase …
posted on
Teva's Copaxone approved for preventative treament of MS - The drug is already approved to treat relapsing-remitting multiple sclerosis, where new symptoms occur suddenly or older symptoms become …